首页> 外国专利> LOCAL VASCULAR DELIVERY OF ADENOSINE A2A RECEPTOR AGONISTS TO REDUCE MYOCARDIAL INJURY.

LOCAL VASCULAR DELIVERY OF ADENOSINE A2A RECEPTOR AGONISTS TO REDUCE MYOCARDIAL INJURY.

机译:腺苷A2A受体激动剂的局部血管输送可减轻心肌损伤。

摘要

A stent or other implantable medical device for the local delivery of a selective adenosine receptor agonist may be utilized to reduce myocardial injury following an acute myocardial infarction. As soon as possible following an acute myocardial infarction a stent or other suitable device comprising and capable of delivering a selective adenosine receptor agonist is positioned in the blood vessel with the occlusion responsible for causing the infarct. Once in position, the stent or other intraluminal device is deployed to remove the occlusion and reestablish blood flow to the specific area, region or tissue volume of the heart. Over a given period of time the selective adenosine receptor agonist elutes from the stent or other device into the downstream coronary blood flow into the hypoxic cardiac tissue for a time sufficient to reduce the level of myocardial injury.
机译:用于局部递送选择性腺苷受体激动剂的支架或其他可植入医疗装置可用于减少急性心肌梗塞后的心肌损伤。在急性心肌梗塞后尽快将包含或能够递送选择性腺苷受体激动剂的支架或其他合适的装置放置在血管中,阻塞引起梗塞。一旦就位,将支架或其他腔内装置展开以消除阻塞并重新建立到心脏特定区域,区域或组织体积的血流。在给定的时间段内,选择性腺苷受体激动剂从支架或其他装置洗脱下来,进入下游缺氧心脏组织的冠状动脉血流,其时间足以减少心肌损伤的程度。

著录项

  • 公开/公告号MX2013005644A

    专利类型

  • 公开/公告日2013-07-03

    原文格式PDF

  • 申请/专利权人 CORDIS CORPORATION;

    申请/专利号MX20130005644

  • 发明设计人 FALOTICO ROBERT;PARKER THEODORE L.;

    申请日2011-11-09

  • 分类号A61L31/10;A61K31/436;A61K31/7076;A61K31/727;A61L31/16;

  • 国家 MX

  • 入库时间 2022-08-21 16:40:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号